Drug Type Gene editing |
Synonyms- |
Target |
Mechanism lipoprotein(a) inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | US | 11 Sep 2023 | |
Atherosclerosis | Preclinical | US | 11 Sep 2023 |